Alejandro
Martín García Sancho
Profesor Asociado CC. Salud
MARÍA DOLORES
CABALLERO BARRIGÓN
Investigadora en el periodo 1998-2022
Publicaciones en las que colabora con MARÍA DOLORES CABALLERO BARRIGÓN (16)
2023
-
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO
British Journal of Haematology, Vol. 203, Núm. 2, pp. 202-211
2022
-
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups
Cancers, Vol. 14, Núm. 22
-
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience
Cancers, Vol. 14, Núm. 11
-
TCL-318 Evaluation of the Antitumor Activity of Amiloride in Peripheral T-Cell Lymphomas Using In-Vitro Models
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S399
2021
-
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Bone Marrow Transplantation, Vol. 56, Núm. 8, pp. 1919-1928
2019
-
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group
British Journal of Haematology, Vol. 184, Núm. 5, pp. 797-807
-
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Cancer Medicine, Vol. 8, Núm. 16, pp. 6955-6966
2017
-
Plitidepsin: Design, development, and potential place in therapy
Drug Design, Development and Therapy, Vol. 11, pp. 253-264
-
Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome
Hematological Oncology, Vol. 35, Núm. 4, pp. 520-527
2012
-
Update on the role of autologous hematopoietic stem cell transplantation in follicular lymphoma
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 4, Núm. 1
2009
2006
-
Treatment options in relapsed or refractory Hodgkin disease patients: The mini-BEAM regimen does exist too [1]
British Journal of Haematology
2005
2004
-
Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: A single-centre sequential-cohort study
Bone Marrow Transplantation, Vol. 34, Núm. 8, pp. 675-682
2001
-
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease
British Journal of Haematology, Vol. 113, Núm. 1, pp. 161-171
1999
-
Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS
Bone Marrow Transplantation, Vol. 23, Núm. 10, pp. 997-1002